Hypertension, Atrial fibrillation, Stroke
Conditions
Interventions
People at high risk of atrial fibrillation:Wearable ECG screening and whole process management based on digital platform.
Patients with atrial fibrillation:Whole process management based on digital platform.
Patients with Stroke:Whole process management based on digital platform.
Sponsors
West China Hospital, Sichuan University
Eligibility
Sex/Gender
All
Age
18 Years to 90 Years
Inclusion criteria
Inclusion criteria: This cohort consisted of three subcohorts, including subcohorts of people at high risk of atrial fibrillation (hypertension and et.al) , atrial fibrillation and stroke, which are not independent. 1. Cohort of people at high risk of atrial fibrillation: (1) Patients with hypertension in rural areas or communities; (2) At least 18 years old; (3) Wear wearable ECG devices voluntarily; (4)Voluntary participation in the whole process management based on the information platform. 2. Atrial Fibrillation cohort: (1) Patients from cohort of people at high risk of atrial fibrillation; (2) Diagnosis of atrial fibrillation by ECG; (3) Voluntary participation in the whole process management based on the information platform. 3. Stroke cohort (1) Source atrial fibrillation cohort; (2) Diagnosed stroke (3) Voluntary participation in the whole process management based on the information platform.
Exclusion criteria
Exclusion criteria: 1. Atrial fibrillation screening cohort: (1) Patients with cardiac pacemaker or ICD; (2) A history of severe skin allergy; (3) Refuse to sign informed consent. 2. Atrial Fibrillation cohort: (1) Mentally ill or cognitively impaired, unable to express themselves correctly; (2) Refuse to sign informed consent. 3.Stroke cohort (1) Mentally ill or cognitively impaired, unable to express themselves correctly; (2) Refuse to sign informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Major adverse cardiovascular events(MACE) ,including cardiac death, nonfatal myocardial infarction, heart failure, nonfatal stroke.; | — |
Secondary
| Measure | Time frame |
|---|---|
| Detection rate of atrial fibrillation;Anticoagulation rate of atrial fibrillation;Compliance with treatment;systemic thromboembolic events;all-cause death;cardiovascular disease hospitalization events;Assessment of quality of life.; | — |
Countries
China
Contacts
Public ContactXiaoyang Liao
West China Hospital, Sichuan Universit
Outcome results
None listed